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Abstract Enteral feeding is the nutritional support of
choice for acutely ill patients with functional gastroin-
testinal tracts who are unable to swallow. Several benefits
including reduced mortality and length of hospital stay
have been associated with early initiation of enteral feed-
ing. However, misplacement of conventional nasoenteric
tubes is relatively common and can result in complications
including pneumothorax. In addition, the need to confirm
the position by X-ray can delay the start of using the tube.
Eliminating these delays can help patients start feeding,
and minimise the adverse impact on initiating hydration
and medication. The purpose of this review was to
critically examine whether electromagnetic sensor-guided
enteral access systems (EMS-EAS) can help overcome the
challenges of conventional nasoenteric feeding tube
placement and confirmation. The Royal Society of Medi-
cine’s library performed two searches on Medline (1946–
March 2014) and Embase (1947–March 2014) covering all
papers on Cortrak or electromagnetic or magnetic guidance
systems for feeding tubes in adults. Results from the lit-
erature search found an agreement between the radio-
graphic and EMS-EAS confirmation of placement. EMS-
EAS virtually eliminated the risk of misplacement and
pneumothorax was not reported. In addition, studies
showed a small decrease in the number of X-rays with
EMS-EAS and a reduced average time to start feeding
compared with blind placement. This review suggests that
EMS-EAS reduces several complications associated with
the misplacement of nasoenteric feeding tubes, and that
there could be considerable improvements in mortality,
morbidity, patient experience and cost if EMS-EAS is used
instead of conventional methods.
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Introduction
John Hunter made the first reported attempts at nasogastric
(NG) or orogastric feeding in 1769 [1]. However, the tech-
nique was used infrequently until Dobbie and Hoffmeister
reported successful outcomes with small-bore, weighted
tubes in 1976 [1]. Today, enteral feeding is the nutritional
support of choice for acutely ill medical and critical care
patients with functional gastrointestinal tracts who are un-
able to swallow [2–4].
Although the optimal time to start enteral nutrition is
uncertain, ‘‘early’’ initiation appears to have significant
advantages. Trials that enrolled critically ill patients
demonstrated several benefits associated with enteral nu-
trition including improvements in nitrogen balance,
splanchnic blood flow, gastrointestinal mucosal barrier
function, mortality among mechanically ventilated patients
and length of hospital stay [2, 3, 5, 6]. Evidence is less
clear in patients suffering with an acute neurovascular
event; protein-energy malnutrition during the first week
after an acute stroke increased the risk of death or Barthel
index B50 on the 30th day of follow-up 3.5-fold, whereas,
the FOOD study, although suggesting a modest absolute
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risk reduction in mortality and poor functional outcome,
was not statistically significant (1.2 %, -4.2 to 6.6,
p = 0.7) [7, 8].
Misplacement of conventional nasoenteric (NG or na-
sojejunal [NJ]) tubes is relatively common and can result in
significant complications [9, 10]. Between September 2005
and March 2011, the National Patient Safety Agency
(NPSA) in the United Kingdom (UK) received reports of
21 deaths and 79 cases of harm related to feeding through
NG tubes misplaced into the lower bronchial tree rather
than the enteral tract.[9]. Due to the voluntary reporting of
these adverse incidents and the reporting of misplaced
tubes only where harm has occurred, the NPSA figures may
underestimate the true incidence. In addition, misplaced
tubes are frequently repositioned before use and therefore
not reported as an incident. Indeed, numerous studies al-
lude to the underreporting of nasoenteric tube misplace-
ment in a variety of settings [3, 10–12].
Other significant harm associated with nasoenteric tube
insertion and misplacement include pneumothorax [10],
vocal cord injury (NG tube syndrome), bronchopleural
fistula, aspiration pneumonia with or without emphysema,
perforation of the membranous trachea or pleural
parenchyma, hydrothorax, mediastinitis, atelectasis and
plural effusions [5, 13]. The true incidence of these com-
plications is unknown.
Several patient-related factors increase the risk of na-
soenteral tube misplacement including tracheal intubation
and mechanical ventilation, depressed levels of con-
sciousness (regardless of cause), vocal cord dysfunction
and swallowing dysfunction [9, 13]. In addition, a reduced
reflex or impaired gag reflex may contribute to poor
recognition of a misplaced NG tube. Unfortunately, pa-
tients most likely to need enteral feeding often have one or
more factors that predispose to misplacement.
Techniques to Minimise the Risk of Misplacement
National Health Service (NHS) England specifies that
healthcare professionals should measure the pH of an
aspirate of approximately 1–2 ml of the gastric contents to
confirm enteral placement. A pH of 1–5.5 confirms the tube
is in the stomach [9]. However, acid pH might be recorded
in the oesophagus in patients with conditions such as hiatus
hernia and gastro-oesophageal reflux. Other patients, such
as those taking proton pump inhibitors or requiring con-
tinuous enteral feeds, will have a neutral or alkaline gastric
pH [3]. A UK study reported obtaining gastric aspirates in
60 % of 43 post-pyloric feeding tube placements that were
suitable for pH readings. The pH was B5 in 44 % (19/43)
of the placements [14]. Another study reported that a
pH\ 5.0 confirmed the gastric placement of 60 % of tubes
[10]. Difficulty obtaining an aspirate may delay the start of
using the tube for feeding, hydration or medication.
NHS England recommends obtaining a chest radiograph
if the pH test does not confirm the correct placement of
nasoenteric tubes [9]. However, radiological misinterpre-
tation is the most common cause of severe harm incidents
associated with nasoenteric tubes reported to the NPSA.
Twelve of the 45 incidents associated with radiological
misinterpretation resulted in fatalities [9].
Bronchial intubation may cause pulmonary trauma be-
tween placement and radiological confirmation of the
inappropriate position [10, 15]. Radiographs are only ac-
curate at the time they are taken and additional radiographs
may be required if the nasoenteric tube is clinically sus-
pected of moving from the initial placement following, for
example, coughing, retching or vomiting. For instance,
between 27 and 42 % of NJ tubes show retrograde mi-
gration into the duodenum or stomach [16], while NG tubes
can move to the oesophagus or post-pylorically. Repeated
X-ray exposure carries a small, but appreciable, carcino-
genic risk. For example, in the UK, diagnostic X-rays ac-
count for about 0.6 % of the cumulative risk of cancer
before the age of 75 years, equivalent to about 700 cases a
year [17].
Furthermore, transfer to the radiology department, along
with the production, interpretation and reporting of X-rays
potentially delays the start of feeding, hydration and
medication. Eliminating these delays helps patients start
tube feeding more rapidly, thereby increasing the proportion
that attain their caloric and nutrient targets, and minimising
delays to the start of hydration and medication [18].
This review examines whether the electromagnetic
sensor-guided enteral access system (hereafter EMS-
EAS)—of which CORTRAKTM (CORPAK MedSystems
UK, Gatwick, UK) is the only example on the UK mar-
ket—helps overcome the challenges of conventional na-
soenteric feeding tube placement and confirmation. EMS-
EAS, a bedside system, uses an electromagnetic sensor to
track and display the anterior and cross-sectional path of a
polyurethane feeding tube and transmitting stylet assembly
during NG or post-pyloric placement [13].
Methods
The Royal Society of Medicine’s library performed two
searches on Medline (1946–March 2014) and Embase
(1947–March 2014) covering
• All papers on Cortrak or electromagnetic or magnetic
guidance systems for feeding tubes in adults. The
search excluded blind placement, endoscopic place-
ment and studies on animals or children.
276 D. Smithard et al.: Electromagnetic Sensor-Guided Enteral Access Systems: A Literature Review
123
• Cost-effectiveness or safety of blind placement of
feeding tubes—excluding endoscopic placement and
studies in animals or children.
The search was restricted to studies published in Eng-
lish. Corpak MedSystems provided selected information
from meetings, which we augmented with further searches
of congress websites. Reference lists were manually sear-
ched to include additional references identified in these
searches and excluded, as far as possible, duplicate studies.
Appendix one shows the search strategies. All authors re-
viewed the results of the literature searches to ensure that
all relevant publications were included.
Results
Accuracy of Placement With EMS-EAS Compared
to X-Ray
Several studies compared gastric or post-pyloric (duode-
num or jejunum) position indicated with EMS-EAS with
that shown on radiographs (Table 1). These studies indi-
cated an agreement between the radiographic and EMS-
EAS confirmation of the tubes.
Bronchial Misplacement
Tables 2 and 3 show the number of nasoenteric tubes
misplaced in the bronchi in studies of conventional place-
ment and EMS-EAS and the number of misplacements
avoided (i.e. where EMS-EAS detected entry into the upper
airway allowing the tube to be repositioned before final
placement). The number of nasoenteric tubes misplaced in
the bronchi indicates that EMS-EAS virtually eliminates
the risk of misplacement.
The literature search identified a single report of a serious
incident arising from unrecognised intra-bronchial placement
using EMS-EAS [19]. CORPAK MedSystems received four
such reports in the UK since launch in 2005 (Corpak Personal
communication. 2014). To place these results in context,
between January 2010 and April 2014, CORPAK MedSys-
tems sold approximately 17,700 EMS-EAS tubes in the UK
alone (Corpak Personal communication. 2014).
Delay in the start of tube feeding
Based on studies that enrolled patients requiring post-py-
loric tubes, the mean of the average time to start of enteral
feeding was 21.5 h with blind placement and 11.5 using
EMS-EAS (Table 4).
Table 1 Radiologically confirmed placements of nasogastric tubes using EMS-EAS
Patients recruited
















25 NA NA 25 25 100.0 Ackerman et al. [28]
74 67 ± 19 Medical, 73
Surgery, 24
Trauma, 3
61 74 82.4 Boyer et al. [39]
52 NA NA 57 57 100.0 Lei et al. [20]
25 NA NA 24 24 100.0 Phang et al. [40]








193 194 99.5 Powers et al. [41]
27 NA NA 20 21 95.2 Priestley et al. [42]







127 127 100.0 Taylor et al. [10]
142 NA NA 135 135 100.0 Wang et al. [38]
Totals
1112 1140 Mean = 97.5 %
ICU intensive care unit, IQR interquartile range, NA not available
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Radiological Exposure
The number of X-rays received was similar between pa-
tients receiving a nasoenteric tube with blind placement
(mean of averages 2.11) and EMS-EAS (mean of averages
1.22, Table 5).
Placement Time
Only one study directly compares the time to confirmed
placement of a NG tube using pH monitoring with EMS-
EAS (Table 5): 11.6 and 9.6 min, respectively [20]. Blind
placement of a post-pyloric tube takes, on average, 42 min
compared with 15.5 min using EMS-EAS (mean of
averages)(Table 6).
Pneumothorax
A reduction in the incidence of pneumothorax and iatro-
genic pneumothorax has been seen with EMS-EAS in the
studies to date (Table 7). CORPAK MedSystems have re-
ceived no reports of pneumothorax in the UK between the
launch of the EMS-EAS in 2005 and April 2014.
Discussion
Early enteral nutrition in acutely ill patients appears to re-
duce mortality and morbidity [2, 3, 5–7]. Nasoenteric
feeding has a recognised morbidity and mortality associated
with misplacement of the tube into the bronchial tree [9, 10].
This review of the literature of EMS-EAS compared with
blind placement suggests that EMS-EAS can reduce the risk
of feeding into the lungs, pneumothorax and time to com-
mence feeding. More rapid and safer tube insertion reduces
morbidity and is cost effective compared to blind placement
and fluoroscopy using a variety of estimates, settings,
countries and outcomes [5, 18, 20–27].
The position of the tube on EMS-EAS and X-ray agreed
in 98 % of cases. It is unclear why in 2 % of cases there
was a difference, however, potential reasons include tube
migration between the NG insertion and radiological con-
firmation, operator error in positioning the tube using
EMS-EAS, patient anatomy and incorrect interpretation of
the X-ray. Nevertheless, given the apparent high level of
confirmation between the enteral feeding tube tip position
using EMS-EAS and X-ray, it seems reasonable that EMS-
EAS could replace radiological confirmation of the na-
soenteric tube’s position for most patients [28]. This avoids
the potential damage to the respiratory tree that might
occur given the delay between misplacement and ra-
diography. Moreover, Sparks et al reported that between 13
and 32 % of subsequent blind intubations were incorrectly
positioned [3]. EMS-EAS eliminates ‘‘the cost and patient
safety burden of [these] additional X-rays’’ [28].
Inadvertent placement into the bronchi occurs in 2–4 %
of blind insertions of nasoenteric tubes. Differences in
patient population, sample size, reporting bias and the
method of identifying tube misplacement might contribute
to variations in the incidence of pulmonary placement of
Table 2 The number of nasoenteric tubes misplaced in the bronchi with conventional placement







Median, 59 (18–98) 27 1822 Aguilar-Nascimento
and Kudsk [15]
214 5 (18–101) 2 242 Hillard et al. [25]
ICU and medical surgical unit, 101 61 3 101 McCutcheon et al. [27]
Non-comparative studies
4190 NA 108 5158 Marderstein et al. [44]
NA NA 14 1100 McWey et al. [45]
740 NA 14 740 Rassias et al. [46]
NA 71 (22–91) 50 3789 Sorokin et al. [11]
Medical and surgical ICU
Inpatient acute care
NA 187 9931 Sparks et al. [3]
NA NA 1 43 Gatt et al. [14]
Totals (%)
406 (1.77) 22926
ICU intensive care unit
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Table 3 The number of nasoenteric tubes misplaced in the bronchi and the number of misplacements avoided with EMS-EAS
Patients recruited















ICU and medical surgical
unit, 84
54 NA 0 84 McCutcheon et al. [27]
Non-comparative studies
715 58 ± 18 NA 0 1154 Koopman et al. [34]








0 194 15 194 Powers et al. [41]
632 63 ± 15 Cardiovascular unit, 23
Medical, 48
TSN, 29
0 904 Powers et al. [47]






0 719 ‘‘on occasion’’ 719 Rivera et al. [48]
NA NA NA 0 483 Stockdale et al. [43]




0 799 26 799 Taylor et al. [30]
200 65 (1–16) NA 0 200 Trottier et al. [49]
25 NA NA 4 25 Ackerman et al. [28]
20 NA Cardiothoracic
General
0 20 Lee et al. [6]
142 NA NA 0 142 2 142 Wang et al. [38]
Totals (%)
0 (0) 4699 47 (4.05) 1160
ICU intensive care unit, NA not available, TSN trauma/surgical/neurological unit
a Attempts where the tube entered the bronchi, but EMS-EAS detected the misplacement allowing the tube to be repositioned before final placement
Table 4 Time to start enteral nutrition with blind and EMS-EAS-
guided placement of post-pyloric tubes
Blind placement (h) EMS-EAS (h) Reference
Comparative studies
22.3 7.8 Gray et al. [5]
28.6 19.7 MacKay et al. [24]
22.7 7.0 McCutcheon et al. [27]
Non-comparative studies
6 (IQR 5–18) Gatt et al. [14]




Table 5 Number of X-rays required to confirm tube position with





2 1 Gray et al. [5]
1.49 1.13 Koopman et al. [34]
1.55 1.45 MacKay et al. [24]
3.40 1.02 McCutcheon et al. [27]
Non-comparative studies
1.5 Aguilar-Nascimento and Kudsk [15]
2.1 Hillard et al. [25]
Mean of the averages
2.11 1.22
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feeding tubes. Up to 80 % of these misplacements are not
clinically detected [13] and require routine X-ray detection
[1]. The potential for serious, but avoidable, complications
is considerable. The NHS used approximately 271,000
nasoenteric tubes during 2008 [29]. Assuming that 2–4 %
of nasoenteric tubes inserted with conventional placement
enter the pulmonary system, there are approximately
5,000–110,00 misplaced tubes per annum, all of which
have the potential to cause significant morbidity and
mortality.
The literature suggests a rate of pneumothorax from
18.7–26 % of bronchial tube placements with an associated
mortality of 2.7–4 % [3]. Sparks et al, for example, re-
ported that 18.7 % of the nasoenteric tubes misplaced into
the bronchial tree resulted in pneumothoraces, while 2.7 %
were fatal [3]. Sorokin et al reported that 26 % of patients
with a misplaced tube experienced pneumothoraces and
other complications, with a mortality rate directly at-
tributed to the misplacement of 4 % [11]. The present re-
view demonstrated a significant reduction in pneumothorax
associated with EMS-EAS use with a single report of a
serious incident arising from unrecognised intra-bronchial
placement using EMS-EAS [19]. The reduction with EMS-
EAS is likely to be because, unlike X-ray, EMS-EAS de-
tects in real-time when a nasoenteric tube enters the upper
reaches of the bronchial tree allowing the healthcare pro-
fessional to reposition the tube before final placement [30].
These figures are considerably higher than the mortality
reported to the NPSA: 21 deaths between September 2005
and March 2011 [9]. This may suggest there is under-re-
porting of harm caused by misplaced nasoenteric tubes,
possibly caused by misattribution of mortality to co-mor-
bidities in this severely ill population. Numerous studies
indicate underreporting of adverse events associated with
pharmaceuticals through spontaneous reports. [31, 32]
There seems to be no reason why spontaneous reports
would not also under-represent adverse events associated
with devices. Indeed, many authors comment that health-
care professionals probably underestimate the prevalence
of, and risks associated with, misplaced nasoenteric tubes
[3, 10–12]. In the study by Sorokin et al, a search of ra-
diology reports identified misplacements. In contrast, their
risk management database did not include any of the
misplacements [11]. Indeed, some commentators report
that they know of cases that were missed by the search for
misplacement. [1] Clearly, there is a pressing need to im-
prove reporting of these potentially fatal adverse events.
Minimising the delay to the start of enteral feeding helps
improve outcomes in critically ill patients [2, 3, 5]. Several
studies suggest that EMS-EAS allows earlier initiation of
enteral feeding, probably through a combination of more
rapid intubation as well as by avoiding X-rays. Similarly,
the median proportion of critically ill people with delayed
gastric emptying that attain the enteral nutrition goal in-
creased from 19 % with conventional NJ tube placement to
between 80 and 100 % following EMS-EAS’s implemen-
tation [33]. The reduction in time to start feeding is con-
sistent across the literature [5, 15, 24, 25, 27, 34]. A recent
intensive care unit study reported that EMS-EAS confirmed
placement of NG tubes took a mean of 9.6 minutes (stan-
dard error [SE] ± 1.7), while patients who required an
X-ray took 122 (SE ± 23; p\ 0.0001) minutes [20],
equivalent to a 92 % reduction if EMS-EAS were used
Table 6 Time needed for conventional placement of feeding tubes





11.6 (SE ± 1.7)a 9.6 (SE ± 1.7) Lei et al. [20]
0.48 (IQRd
0.34–1.09)
Roa et al. [2]
9 (IQR 6–14)b Taylor et al. [33]




60 10 Phang et al. [40]
37 12.5 Stockdale et al. [22]
28 (10-90) Cresci et al. [50]
5.9c Deane et al. [37]
30 Dolan et al. [21]
12.4 Duflou et al. [36]
18 (IQR 14–30) Gatt et al. [14]
11 (IQR 6–19) Holzinger et al. [51]
7.6 (range 1–20) Kaffarnik et al. [52]
18 (range 3-55) Lee et al [6]
16.3 (SD ± 11.8) Mathus-Vliegen et al.
[53]14.8 (SD ± 14.7)
26.2 (SD ± 19.3)
12 (range 1–52) Powers et al. [41]
6.16 (IQRd
3.55–9.03)
Roa et al. [2]
30 ± 17 Trottier et al. [49]
12.6 (ranged
5.3–34.4)
Young et al. [54]
20.12 (SD ± 3.71) Wang et al. [38]
Mean of averages
42 15.5
IQR interquartile range, SD standard deviation
a Based on pH paper
b Last 20 patients to allow for training effect
c Last 50 patients to allow for training effect
d unclear from paper
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instead of X-ray confirmation. In this study, the time to
feeding was 3.98 h with conventional placement of NG
tubes compared to 2.58 h using EMS-EAS (p = 0.049)
[20]. The present review suggests that healthcare profes-
sionals can insert NG and post-pyloric tubes more rapidly
using EMS-EAS than conventional placement (Table 5),
although times vary considerably. The delay between in-
tubation and X-ray depends on numerous factors including
the distance between the ward and the radiological suite as
well service provision, such as operator experience, op-
erator training and limited numbers of radiographers over
weekends and public holidays.
In the UK, NHS England guidance recommends pH
testing and X-ray testing only if the position is not con-
firmed. The use of pH may confirm that the tip is in an
acidic environment, but does not confirm subdiaphragmatic
placement as the patient may have a hiatus hernia or reflux
disease—the prevalence of gastro-oesophageal reflux in
Western Europe is estimated to lie between 8.8 and 25 %
[35]. Taylor et al [10] reported that pH test of\5.0 con-
firmed gastric placement in only 60 % of tubes. Another
UK study reported obtaining gastric aspirates in 60 % of 43
intubations and a pH reading of B5 in 44 % [14]. There-
fore, it is estimated that in the UK 40 % of patients with an
NG placement (approximately 110,000) will need an X-ray
following failure to measure pH. This use of X-rays in-
troduces a burden of radiation for patients as well as a
significant cost (the cost of a conventional X-ray in the
NHS is approximately £25, the 110,000 X-rays cost the UK
taxpayer £2.7 million annually).
Limitations and Future Research
This review is subject to several limitations that are com-
mon to literature reviews. There were no prospective ran-
domised controlled trials reported in the literature and all
studies were cohort or case-control studies. Methodological
uncertainties (for example, whether the investigators used
the same start and end points when assessing timings, and
differences in service settings and protocols) can compli-
cate interpretation of these data. Furthermore, the literature
was predominantly from the USA and UK where different
protocols are followed that may influence aspects such as
the need for X-ray confirmation following tube placement.
Many studies are posters or available only as abstracts
and there appears to be an overlap in some of the published
cohorts, although we endeavoured, as far as possible, to
exclude potential duplicates. The studies came from di-
verse settings, enrolled diverse cohorts and employed di-
verse methodologies. These differences and the level of
detail presented in the posters and papers precluded a meta-
analysis, which was our original intention. This highlights
the need for formal prospective studies ideally in a single
setting (e.g. stroke units and a defined patient cohort from
the intensive care unit).
The true costs of an X-ray are dependent upon the
healthcare setting in which the X-ray are taken. Relatively
few studies ascertain the cost-effectiveness of EMS-EAS
from the perspective of the NHS. A study from St Tho-
mas’ Hospital suggested that using EMS-EAS for 57 in-
sertions in 52 patients requiring NG placement potentially
Table 7 Number of iatrogenic pneumothoraces following blind- and EMS-EAS-guided placement
Blind placement EMS-EAS Reference
Cases Number of patients % (range) Cases Number of patients % (range)
Comparative studies
11 831 1.32 0 715 0 Koopman et al. [34]
1 101 0.99 0 84 0 McCutcheon et al. [27]
Non-comparative studies
9 729 1.23 Aguilar-Nascimento and Kudsk [15]
9 4190 0.21 Marderstein et al. [44]
4 1100 0.36 McWey et al. [45]
5 740 0.68 Rassias et al. [46]
8 2079 0.38 Sorokin et al. [11]
0 194 0 Powers et al. [41]
0 616 0 Rivera et al.
0 483 0 Stockdale et al. [22]
0 69 0 Taylor et al. [30]
0 142 0 Wang et al. [38]
Total
47 9770 0.48 0 2303 0
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avoided 46 chest X-rays, which equated to a saving of £2300.
The costs estimated in this study are from one author’s in-
stitution and represent inter-departmental cross charging
rather than an absolute cost (This study estimated that an
X-ray cost £50.) [20] Costs are therefore likely to be un-
derestimated and do not include indirect costs such as those
associated with treating cancers caused by X-rays, the con-
sequences of delayed nutritional support, hydration or
medication, and the opportunity costs associated when
healthcare professionals accompany patients to X-ray.
Clearly, there is a need for further economic studies en-
compassing the range of costs and consequences associated
with conventional placement and EMS-EAS.
Finally, it is possible that the effect of EMS-EAS may
be overestimated. Centres that participate in clinical studies
may be more experienced and, therefore, less likely to
cause adverse events than might be expected in general
clinical practice. Several studies report a learning curve or
comment that experience enhances the success of EMS-
EAS and nastoenteric tube placement [3, 14, 33, 36–38].
For example, Deane et al reported that the time to place a
post-pyloric tube declined from 20.8 min in the first 10
patients to 5.9 min in the next 50 placements (p = 0.003)
which underlines the importance of training [37]. Future
studies should address this.
Conclusions
This literature review of the use of EMS-EAS and blind
placement suggests that there is a prima facie case that EMS-
EAS reduces the risk of bronchial misplacement of feeding
tubes, pneumothorax, time to commence feeding and,
presumably, other complications associated with the mis-
placement of nasoenteric feeding tubes. This suggests that
there are considerable improvements in mortality, morbidity,
patient experience and cost if EMS-EAS is used instead of
conventional methods to confirm NG position. Further
prospective studies and analyses need to confirm the findings
in this review.
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Appendix: Search Strategies
Summary of search: All papers on Cortrak or electromag-
netic/magnetic guidance systems for feeding tubes—ex-
cluding blind placement, endoscopic placement and studies
on animals or children bymanually scanning the final results.
Set# Searched for Databases Results
S11 s8 or s10 Embase, Embase Alert, MEDLINE 197a
S10 (s9 not (s8 or ‘‘magnetic resonance’’ or ‘‘magnet [6a] endoscop [6a]’’
or mei or mri or mris)) and la (english)
Embase, Embase Alert, MEDLINE 124
S9 magnet [6a] and (s3 or s4) Embase, Embase Alert, MEDLINE 1356
S8 (s1 or s2 or s7) and la (english) Embase, Embase Alert, MEDLINE 78
S7 (s3 or s4) and (s5 or s6) Embase, Embase Alert, MEDLINE 84
S6 electromagnet [6a] or ‘‘electro magnet [6a]’’ Embase, Embase Alert, MEDLINE 71272
S5 MESH.EXACT (‘‘Electromagnetic Fields’’) OR MESH.EXACT
(‘‘Electromagnetic Phenomena’’) OR EMB.EXACT
(‘‘electromagnetic radiation’’) OR EMB.EXACT (‘‘electromagnetic field’’)
Embase, Embase Alert, MEDLINE 38915
S4 (Enteral [2a] or enteric or post-pyloric or pyloric or nasointestinal or intestinal
or nasojejunal or jejunal or nasogastric or gastric or gastrointestinal or gi
or orogastric or nasoduodenal or duodenal or intraintestinal or intragastric
or nasoenteral [2a] or nasoenteric or nose or nasal or feeding) near/5
(tube [1a] or device [1a] or catheter [1a] or intubat [4a])
Embase, Embase Alert, MEDLINE 62430
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continued
Set# Searched for Databases Results
S3 MESH.EXACT (‘‘Enteral Nutrition’’) OR MESH.EXACT (‘‘Intubation,
Gastrointestinal’’) OR EMB.EXACT (‘‘enteric feeding’’) OR EMB.EXACT
(‘‘nose feeding’’) OR EMB.EXACT (‘‘feeding apparatus’’) OR
EMB.EXACT.EXPLODE (‘‘digestive tract intubation’’) OR
EMB.EXACT.EXPLODE (‘‘nasogastric tube’’) OR EMB.EXACT
(‘‘stomach tube’’)
Embase, Embase Alert, MEDLINE 60610
S2 ‘‘enteral access system’’ or egnt Embase, Embase Alert, MEDLINE 9
S1 Cortrak Embase, Embase Alert, MEDLINE 24
a The search strategy retrieved a number of references that were then manually searched to find the most relevant
Set# Searched for Databases Results





S2 (enteral [2a] or enteric or post-pyloric or pyloric or nasointestinal or intestinal or nasojejunal or
jejunal or nasogastric or gastric or orogastric or gastrointestinal or gi or nasoduodenal or duodenal
or intraintestinal or intragastric or nasoenteral [2a] or nasoenteric or nose or nasal or feeding)




S1 MESH.EXACT (‘‘Enteral Nutrition’’) OR MESH.EXACT (‘‘Intubation, Gastrointestinal’’) OR
EMB.EXACT (‘‘enteric feeding’’) OR EMB.EXACT (‘‘nose feeding’’) OR EMB.EXACT
(‘‘feeding apparatus’’) OR EMB.EXACT.EXPLODE (‘‘digestive tract intubation’’) OR




a The search strategy retrieved a number of references that were then manually searched to find the most relevant
Cost-effectiveness or safety of blind placement of feeding tubes—excluding endoscopic placement, studies on animals
or children, and a small number of references duplicated in the Cortrak search by manually scanning the final results.
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